Document 0051
 DOCN  M9460051
 TI    [Erythropoietin for autologous transfusion. Use in a case of severe
       anemia with allo-immunization]
 DT    9404
 AU    Page B; Chauveau D; Mauriat P; Chauvaud S; Audat F; Cartron J;
       Departement de Nephrologie, Hopital Necker, Paris.
 SO    Presse Med. 1994 Jan 22;23(2):80-1. Unique Identifier : AIDSLINE
       MED/94188328
 AB    In view of the transfusional risks of viral transmission (notably HIV),
       autologous transfusion is increasingly used; it is often the only
       possible type of transfusion. A 42-year-old woman with lupus
       erythematosus, chronic renal failure and triple cardiac valve disease
       demanding surgery was admitted for multifactorial severe anaemia.
       Treatment with erythropoietin (8000 units/day) iron replenishment,
       corticosteroids and polyvalent immunoglobulins was initiated. The
       patient was operated upon in April 1990. A preoperative cell-saver
       autotransfusion was performed during surgery. The postoperative period
       was uneventful. Homologous transfusion was not necessary. In this case
       where homologous transfusion was ruled out, erythropoiesis stimulated by
       erythropoietin enabled autotransfusion and cardiac surgery to be
       performed.
 DE    Adult  Anemia/BLOOD/*DRUG THERAPY/ETIOLOGY  Aortic Valve
       Insufficiency/*COMPLICATIONS/SURGERY  Blood Transfusion,
       Autologous/*METHODS  Case Report  English Abstract
       Erythropoietin/*THERAPEUTIC USE  Female  Human  Immunotherapy  Kidney
       Failure, Chronic/COMPLICATIONS  Lupus Erythematosus,
       Systemic/COMPLICATIONS  Mitral Valve
       Insufficiency/*COMPLICATIONS/SURGERY  Tricuspid Valve
       Insufficiency/COMPLICATIONS/SURGERY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).